Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb · NCT07116967
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 3
- Target enrollment
- 3040
- US sites recruiting
- 91
- Study start
- September 22, 2025
- Record last updated
- October 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis
Being studied: Deucravacitinib; Ustekinumab
Conditions: Plaque Psoriasis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Participants with moderate-to-severe plaque psoriasis:
- Deemed by the Investigator to be a candidate for phototherapy or systemic treatment for psoriasis, including ustekinumab;
- Have at least 1 of the following cardiovascular risk factors:
- Current cigarette smoker
- Diagnosis of hypertension
- Diagnosis of hyperlipidemia
- Diabetes mellitus type 1 or 2
- History of one or more of the following cardiovascular events: Coronary intervention (PCI) or coronary artery bypass grafting (CABG), myocardial infarction (heart attack), cardiac arrest, hospitalization for unstable angina, acute coronary syndrome, stroke, or transient ischemic attack
- Obesity
- Family history of premature coronary heart disease or sudden death in a first-degree male relative younger than 55 years of age or in a first-degree female relative younger than 65 years of age.
Exclusion Criteria
- Participants must not have recent history of 1 of the following cardiovascular events: MI, stroke, or coronary revascularization, or VTE within 90 days prior to Day 1.
- Participants must not have unstable CVD, defined as a recent clinical cardiovascular event (eg, unstable angina, rapid atrial fibrillation), or a cardiac hospitalization (eg, pacemaker implantation, HF) within 90 days prior to Day 1.
- Participants must not have evidence of active cancer or history of cancer (solid organ or hematologic malignancy including myelodysplastic syndrome) or lymphoproliferative disease within the previous 5 years (other than resected cutaneous basal cell or squamous cell carcinoma, or carcinoma of cervix in situ that has been treated with no evidence of recurrence).
- Other protocol define inclusion/exclusion criteria apply.
Recruiting US locations
Medical Dermatology Specialists - Phoenix
Phoenix, AZ 85006-2722
Site contact: Margaret Kessler, Site 0107 · 602-354-5770
Saguaro Dermatology - Phoenix
Phoenix, AZ 85008
Site contact: Dathan Hamann, Site 0495
Omni Dermatology
Phoenix, AZ 85018
Site contact: Andrew Racette, Site 0496
Alliance Dermatology
Phoenix, AZ 85032
Site contact: Sadra Jazayeri, Site 0169 · 602-761-2502
Scottsdale Clinical Trials
Scottsdale, AZ 85260
Site contact: Todd Dreitzler, Site 0432 · 480-382-7909
Omni Dermatology
Tempe, AZ 85282
Site contact: Jeffrey Dickman, Site 0501
Clinical Trials Institute of Northwest Arkansas
Bentonville, AR 72712
Site contact: Mildred Clifton, Site 0335
Northwest Arkansas Clinical Trials Center (NWACTC), PLLC
Rogers, AR 72758
Site contact: Cheryl Hull, Site 0135 · 479-254-9652
California Dermatology & Clinical Research Institute
Encinitas, CA 92024
Site contact: Stacy Smith, Site 0187 · 8585716800x114
T. Joseph Raoof MD Inc
Encino, CA 91436
Site contact: TOORAJ RAOOF, Site 0149 · 818-788-5060
First OC Dermatology - Fountain Valley
Fountain Valley, CA 92708
Site contact: Vivian Laquer, Site 0132 · 714-531-2966
Center For Dermatology Clinical Research, Inc.
Fremont, CA 94538
Site contact: Sunil Dhawan, Site 0087 · 510-797-0140
Marvel Clinical Research
Huntington Beach, CA 92647
Site contact: David Rayhan, Site 0176 · 714-375-5970
Dermatology Research Associates - Howard Sofen, MD
Los Angeles, CA 90045
Site contact: Howard Sofen, Site 0179 · 310-337-7171
Wallace Skin & Body Institute
Los Angeles, CA 90056-1660
Site contact: Paul Wallace, Site 0192 · 213-699-9444
Northridge Clinical Trials - Elite Clinical Network
Northridge, CA 91325
Site contact: Navid Ezra, Site 0411 · 818-350-7483
Cura Clinical Research - Palmdale
Palmdale, CA 93551
Site contact: Aram Kechichian, Site 0426 · 833-525-2872
Pasadena Clinical Trials
Pasadena, CA 91101
Site contact: Tzu-Jen Tzao, Site 0420 · 626-822-6554
Empire Clinical Research - Pomona
Pomona, CA 91767
Site contact: Radhika Shah, Site 0387 · 909-981-5321
Integrative Skin Science and Research
Sacramento, CA 95815
Site contact: Raja Sivamani, Site 0316 · 510-847-6713
UC Davis Dermatology Clinic
Sacramento, CA 95816
Site contact: Emanual Maverakis, Site 0038 · 916-734-8254
Cura Clinical Research - Santa Clarita
Santa Clarita, CA 91355
Site contact: Bernard Raskin, Site 0427 · 833-525-2872
Institute of Clinical Research and Consulting, Inc., d/b/a Clinical Science Institute
Santa Monica, CA 90403
Site contact: Paul Yamauchi, Site 0306 · 310-828-8887
Advanced Dermatology and Skin Cancer Institute - Beverly Hills
Sherman Oaks, CA 91403
Site contact: Michael Lin, Site 0171 · 661-705-9710
Unison Clinical Trials
Sherman Oaks, CA 91403
Site contact: Shahram Jacobs, Site 0128 · 818-981-1555
Golden State Dermatology - Ygnacio Valley Road
Walnut Creek, CA 94598-3335
Site contact: Michael Wang, Site 0181 · 507-261-3758
Clarity Dermatology PLLC - Castle Rock
Castle Rock, CO 80109
Site contact: James Jensen, Site 0494
Skin Care Research LLC (SCR) - Boca Raton
Boca Raton, FL 33486
Site contact: Ann Reed, Site 0164 · 561-948-3116
Florida Academic Dermatology Center
Coral Gables, FL 33134
Site contact: Francisco Kerdel, Site 0105 · 305-324-2110
Accel Research Sites - Maitland Clinical Research Unit
Maitland, FL 32751
Site contact: Nicole Swenson, Site 0478
Driven Research LLC
Miami, FL 33126
Site contact: Javier Alonso-Llamazares, Site 0070 · 305-677-2275
Miami Dermatology and Laser Research
Miami, FL 33133
Site contact: Jill Waibel, Site 0313 · 305-279-6060
International GCC Research
Miami, FL 33135
Site contact: Gilberto Jimenez, Site 0148 · 786-521-9650
BioResearch Partner (BRP) - Miami
Miami, FL 33155
Site contact: Oscar Hevia, Site 0493
Renstar Medical Research
Ocala, FL 34471
Site contact: Ashley Cauthen, Site 0082 · 352-629-5800
LENUS Research
Sweetwater, FL 33172
Site contact: John Niven, Site 0124 · 608-848-8900
Hamilton Dermatology (Atlanta Dermatology, Vein & Research Center, LLC)
Alpharetta, GA 30022
Site contact: Tiffani Hamilton, Site 0304 · 770-255-2533
Velocity Clinical Research, Savannah
Savannah, GA 31406
Site contact: Paul Bradley, Site 0419 · 402-933-6501
Endeavor Health Clinical Trials
Skokie, IL 60077
Site contact: Stephanie Mehlis, Site 0138 · 847-663-8530
Deaconess Clinic Downtown
Evansville, IN 47708
Site contact: Jamie Mull, Site 0168 · 812-858-4508
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, IN 46250
Site contact: Scott Fretzin, Site 0077 · 317-516-5030
Southern Indiana Clinical trials
New Albany, IN 47150
Site contact: Megan Landis, Site 0104 · 812-734-3881
Equity Medical - Bowling Green
Bowling Green, KY 42104
Site contact: David Johnson, Site 0435
Physician Skin Care, PLLC
Louisville, KY 40217
Site contact: Leon Kircik, Site 0096 · 502-451-9000
Clinical Trials Management, LLC - Northshore Office
Covington, LA 70433
Site contact: Martha Stewart, Site 0449 · 985-900-2400
Shondra L. Smith, MD - Dermatology and Advanced Aesthetics
Lake Charles, LA 70605
Site contact: Shondra Smith, Site 0163 · 337-477-0010
Clinical Trials Management
Metairie, LA 70006
Site contact: Robert Koppel, Site 0166 · 504-455-1310
Tulane University School of Medicine - Tulane Dermatology & Multispecialty Clinic
New Orleans, LA 70112
Site contact: Erin Boh, Site 0069 · 504-988-5114
Lawrence J. Green, MD. LLC
Rockville, MD 20850
Site contact: Lawrence Green, Site 0314 · 301-610-0663
U.S. Dermatology Partners Rockville
Rockville, MD 20850
Site contact: Benjamin Lockshin, Site 0331 · 301-355-3183
Metro Boston Clinical Partners
Brighton, MA 02135
Site contact: Mark Amster, Site 0100 · 617-783-7100
Kuchnir Dermatology & Dermatologic Surgery
Milford, MA 01757
Site contact: Shiu-Chung Au, Site 0409 · 508-251-9150
Oakland Hills Dermatology
Auburn Hills, MI 48326-3396
Site contact: Christofer Buatti, Site 0090 · 248-858-2255
Michigan Center for Skin Care Research
Clinton Township, MI 48038-1137
Site contact: Mary Veremis-Ley, Site 0329 · 586-286-7325
Somerset Skin Centre
Troy, MI 48084-5260
Site contact: George Murakawa, Site 0145 · 248-244-8448
Michigan Dermatology Institute - Waterford
Waterford, MI 48328-3277
Site contact: Cory Rubin, Site 0320
Minnesota Clinical Study Center (MCSC)
New Brighton, MN 55112
Site contact: Steven Kempers, Site 0033 · 763-571-7202
Saint Louis University
St Louis, MO 63110
Site contact: Maria Hurley, Site 0298 · 800-758-3678
Las Vegas Clinical Trials, LLC
North Las Vegas, NV 89030-7193
Site contact: Alton Walters, Site 0396 · 702-637-3223
StracSkin
Portsmouth, NH 03801
Site contact: Abel Jarell, Site 0460 · 603-319-7625
+ 31 more on the official record.
Study contacts (from the official record)
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
- First line of the email MUST contain NCT # and Site #.
Similar studies in Arizona
All dermatology studies in Arizona →- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- Phoenix, AZ + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Nektar Therapeutics
- Location
- Phoenix, AZ + 18 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Sanofi
- Location
- Scottsdale, AZ + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Chandler, AZ + 45 other US sites
- Eligibility basics
- Ages 18+